Use of Neuromuscular Blocking Agents and Neuromuscular Monitoring in 7 Danish Teaching Hospitals - a Cross-sectional Study
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Cisatracurium besilate (Primary) ; Mivacurium chloride (Primary) ; Neostigmine (Primary) ; Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Suxamethonium chloride (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 22 Feb 2017 Planned primary completion date changed from 1 Jan 2017 to 1 May 2017.
- 22 Feb 2017 Status changed from not yet recruiting to recruiting.
- 29 Sep 2016 New trial record